Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Wishes and needs of community-dwelling older persons concerning general practice: A qualitative study.

van Blijswijk SCE, de Waard CS, van Peet PG, Keizer D, von Faber M, de Waal MWM, den Elzen WPJ, Gussekloo J, Blom JW.

PLoS One. 2018 Jul 17;13(7):e0200614. doi: 10.1371/journal.pone.0200614. eCollection 2018.

2.

Prescribing and deprescribing antihypertensive medication in older people by Dutch general practitioners: a qualitative study.

van Middelaar T, Ivens SD, van Peet PG, Poortvliet RKE, Richard E, Pols AJ, Moll van Charante EP.

BMJ Open. 2018 Apr 20;8(4):e020871. doi: 10.1136/bmjopen-2017-020871.

3.

Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study.

van der Ploeg MA, Poortvliet RK, van Blijswijk SC, den Elzen WP, van Peet PG, de Ruijter W, Blom JW, Gussekloo J.

PLoS One. 2016 Dec 2;11(12):e0166857. doi: 10.1371/journal.pone.0166857. eCollection 2016.

4.

Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?

van Peet PG, Gussekloo J, den Elzen WP, Blom JW, de Waal MW, de Ruijter W.

Scand J Prim Health Care. 2015;33(4):260-8. doi: 10.3109/02813432.2015.1117281.

5.

Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide.

Poortvliet RK, van Peet PG, de Craen AJ, Mertens BJ, Mooijaart SP, Wijsman LW, Drewes YM, Ford I, Sattar N, Jukema JW, Stott DJ, de Ruijter W, Gussekloo J.

Eur J Prev Cardiol. 2016 Jul;23(10):1104-13. doi: 10.1177/2047487315617908. Epub 2015 Nov 24.

PMID:
26603744
6.

GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands.

van Peet PG, Drewes YM, Gussekloo J, de Ruijter W.

Br J Gen Pract. 2015 Nov;65(640):e739-47. doi: 10.3399/bjgp15X687373.

7.

N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.

Wijsman LW, Sabayan B, van Vliet P, Trompet S, de Ruijter W, Poortvliet RK, van Peet PG, Gussekloo J, Jukema JW, Stott DJ, Sattar N, Ford I, Westendorp RG, de Craen AJ, Mooijaart SP.

Ann Neurol. 2014 Aug;76(2):213-22. doi: 10.1002/ana.24203. Epub 2014 Jul 9.

PMID:
24942833
8.

Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.

van Peet PG, de Craen AJ, Gussekloo J, de Ruijter W.

Age (Dordr). 2014 Jun;36(3):9660. doi: 10.1007/s11357-014-9660-1. Epub 2014 May 8.

9.

NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.

van Peet PG, Drewes YM, de Craen AJ, Gussekloo J, de Ruijter W.

PLoS One. 2013 Nov 21;8(11):e81400. doi: 10.1371/journal.pone.0081400. eCollection 2013.

10.

Prognostic value of cardiovascular disease status: the Leiden 85-plus study.

van Peet PG, Drewes YM, de Craen AJ, Westendorp RG, Gussekloo J, de Ruijter W.

Age (Dordr). 2013 Aug;35(4):1433-44. doi: 10.1007/s11357-012-9443-5. Epub 2012 Jul 4.

Supplemental Content

Loading ...
Support Center